Guardian Pharmacy Services (NYSE:GRDN) Shares Down 4.9% – Should You Sell?

Guardian Pharmacy Services, Inc. (NYSE:GRDN) fell 4.9% during mid-day trading on Wednesday. The company traded as low as $39.99 and last traded at $39.8040. 36,665 shares were traded during mid-day trading, a decline of 91% from the average daily volume of 426,018 shares. The stock had previously closed at $41.87.

Analysts Set New Price Targets

GRDN has been the subject of a number of recent research reports. Wall Street Zen raised Guardian Pharmacy Services from a “hold” rating to a “buy” rating in a research note on Saturday, October 17th. KeyCorp began coverage on shares of Guardian Pharmacy Services in a research report on Tuesday, September 22nd. They issued an “overweight” rating and a $52.00 price target on the stock. Weiss Ratings upgraded Guardian Pharmacy Services from a “buy (b-)” rating to a “buy (b)” rating in a research note on Thursday, October 8th. Truist Financial increased their price target on shares of Guardian Pharmacy Services from $47.00 to $51.00 and gave the company a “buy” rating in a report on Monday, September 21st. Finally, Oppenheimer lifted their price objective on Guardian Pharmacy Services from $43.00 to $49.00 and gave the stock an “outperform” rating in a report on Friday, August 7th. Nine analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $45.57.

Guardian Pharmacy Services Trading Up 1.9%

The firm has a market capitalization of $1.98 billion, a price-to-earnings ratio of 38.56, a P/E/G ratio of 2.04 and a beta of 0.03. The firm has a fifty day moving average price of $40.90 and a 200 day moving average price of $39.96.

Guardian Pharmacy Services (NYSE:GRDN) last announced its earnings results on Thursday, August 6th. The company reported $0.29 EPS for the quarter, topping the consensus estimate of $0.26 by $0.03. The company had revenue of $351.77 million for the quarter, compared to analysts’ expectations of $340.45 million. Guardian Pharmacy Services had a return on equity of 29.97% and a net margin of 4.50%. As a group, equities analysts predict that Guardian Pharmacy Services, Inc. will post 1.18 EPS for the current fiscal year.

Hedge Funds Weigh In On Guardian Pharmacy Services

Several hedge funds have recently added to or reduced their stakes in GRDN. Kings Path Partners LLC bought a new position in shares of Guardian Pharmacy Services in the 3rd quarter valued at about $420,000. Nisa Investment Advisors LLC grew its holdings in Guardian Pharmacy Services by 53.5% during the third quarter. Nisa Investment Advisors LLC now owns 1,050 shares of the company’s stock valued at $43,000 after purchasing an additional 366 shares during the period. Ellsworth Advisors LLC acquired a new position in shares of Guardian Pharmacy Services in the 3rd quarter valued at $1,141,000. State of Alaska Department of Revenue grew its stake in Guardian Pharmacy Services by 105.9% in the third quarter. State of Alaska Department of Revenue now owns 2,390 shares of the company’s stock valued at $97,000 after acquiring an additional 1,229 shares during the period. Finally, Arizona State Retirement System grew its stake in Guardian Pharmacy Services by 53.0% in the second quarter. Arizona State Retirement System now owns 8,393 shares of the company’s stock valued at $351,000 after acquiring an additional 2,907 shares during the period.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc is a provider of pharmacy services focused primarily on residents of long-term care and other institutional healthcare settings. Through its network of pharmacies, the company supplies prescription medications and related pharmacy support to assisted living communities, skilled nursing facilities, behavioral health organizations, and other care providers.

The company’s services include medication dispensing and packaging, prescription delivery, medication management, clinical pharmacy support, and technology-enabled tools designed to help caregivers and healthcare professionals manage residents’ medication regimens.